Patents by Inventor John Arthur

John Arthur has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL PHARMACEUTICAL FORMULATIONS
    Publication number: 20260115134
    Abstract: The present invention relates to new extended release pharmaceutical compositions and methods of use thereof for the treatment of disorders.
    Type: Application
    Filed: October 17, 2024
    Publication date: April 30, 2026
    Inventors: Andreas SOMMER, Chengzhi ZHANG, John CARTER, John ARTHUR, Margaret BRADBURY
  • NOVEL PHARMACEUTICAL FORMULATIONS
    Publication number: 20260115135
    Abstract: The present invention relates to new extended release pharmaceutical compositions and methods of use thereof for the treatment of disorders.
    Type: Application
    Filed: December 13, 2024
    Publication date: April 30, 2026
    Inventors: Andreas SOMMER, Chengzhi ZHANG, John CARTER, John ARTHUR, Margaret BRADBURY
  • MODULAR BUILDING SYSTEM
    Publication number: 20260092441
    Abstract: A system comprising modular parts arranged to be assembled to form at least part of a structure, the system including: a plurality of interengageable modules arranged to be fixed together; wherein the plurality of modules comprises at least one module forming an opening in the structure; wherein each module includes one or more frame elements; and wherein the modules are arranged such that in the assembled structure, the frame elements of the module at least partly transmit loads between adjacent modules, through the structure.
    Type: Application
    Filed: September 12, 2023
    Publication date: April 2, 2026
    Inventors: John Arthur, Robert Barker
  • PHARMACEUTICAL FORMULATIONS
    Publication number: 20230355514
    Abstract: The present invention relates to new extended release pharmaceutical compositions and methods of use thereof for the treatment of disorders.
    Type: Application
    Filed: February 21, 2023
    Publication date: November 9, 2023
    Inventors: Andreas SOMMER, Chengzhi ZHANG, John CARTER, John ARTHUR, Margaret BRADBURY
  • Head assembly with facial insert for crash test dummy
    Patent number: 11200816
    Abstract: A head assembly for a crash test dummy includes a skull, a head skin disposed over the skull, and a facial insert disposed between the skull and the head skin and having a plurality of defined cell structures to achieve a biomechanical response that provides for evaluation of potential head injuries during vehicle crash testing.
    Type: Grant
    Filed: December 19, 2017
    Date of Patent: December 14, 2021
    Assignee: Humanetics Innovative Solutions, Inc.
    Inventors: Zhenwen Jerry Wang, John Arthur, Dominic Isopi
  • NOVEL PHARMACEUTICAL FORMULATIONS
    Publication number: 20210322308
    Abstract: The present invention relates to new extended release pharmaceutical compositions and methods of use thereof for the treatment of disorders.
    Type: Application
    Filed: January 12, 2021
    Publication date: October 21, 2021
    Inventors: Andreas SOMMER, Chengzhi ZHANG, John CARTER, John ARTHUR, Margaret BRADBURY
  • NOVEL PHARMACEUTICAL FORMULATIONS
    Publication number: 20210205214
    Abstract: The present invention relates to new extended release pharmaceutical compositions and methods of use thereof for the treatment of disorders.
    Type: Application
    Filed: March 3, 2021
    Publication date: July 8, 2021
    Inventors: Andreas SOMMER, Chengzhi ZHANG, John CARTER, John ARTHUR, Margaret BRADBURY
  • Pharmaceutical formulations
    Patent number: 10966922
    Abstract: The present invention relates to new extended release pharmaceutical compositions and methods of use thereof for the treatment of disorders.
    Type: Grant
    Filed: July 12, 2019
    Date of Patent: April 6, 2021
    Assignee: Auspex Pharmaceuticals, Inc.
    Inventors: Andreas Sommer, Chengzhi Zhang, John Carter, John Arthur, Margaret Bradbury
  • NOVEL PHARMACEUTICAL FORMULATIONS
    Publication number: 20190328661
    Abstract: The present invention relates to new extended release pharmaceutical compositions and methods of use thereof for the treatment of disorders.
    Type: Application
    Filed: July 12, 2019
    Publication date: October 31, 2019
    Inventors: Andreas SOMMER, Chengzhi ZHANG, John CARTER, John ARTHUR, Margaret BRADBURY
  • NOVEL PHARMACEUTICAL FORMULATIONS
    Publication number: 20190133935
    Abstract: The present invention relates to new extended release pharmaceutical compositions and methods of use thereof for the treatment of disorders.
    Type: Application
    Filed: November 1, 2018
    Publication date: May 9, 2019
    Inventors: Andreas SOMMER, Chengzhi ZHANG, John CARTER, John ARTHUR, Margaret BRADBURY
  • Formulations And Pharmacokinetics Of Deuterated Benzoquinoline Inhibitors Of Vesicular Monoamine Transporter 2
    Publication number: 20190083484
    Abstract: The present invention relates to new pharmaceutical compositions comprising benzoquinoline compounds, and methods to inhibit vesicular monoamine transporter 2 (VMAT2) activity in a subject for the treatment of chronic hyperkinetic movement disorders.
    Type: Application
    Filed: October 17, 2018
    Publication date: March 21, 2019
    Inventors: Andreas Sommer, Chengzhi Zhang, John Carter, John Arthur, Margaret Bradbury, Thomas Gant, Manouchehr Shahbaz
  • REDUCED SODIUM POLOXAMER-188 FORMULATIONS AND METHODS FOR USE
    Publication number: 20190076466
    Abstract: Provided is a sterile, injectable solution comprising: poloxamer 188 and water for injection, wherein the sterile, injectable solution is reduced in sodium and/or substantially sodium-free. Also provided are methods for using the solution.
    Type: Application
    Filed: July 7, 2016
    Publication date: March 14, 2019
    Applicant: LIFERAFT BIOSCIENCES
    Inventors: R. Martin Emanuele, William Hoye, John Arthur, Stewart Smith, Scott Stern
  • Pharmaceutical formulations
    Patent number: 10166183
    Abstract: The present invention relates to new extended release pharmaceutical compositions and methods of use thereof for the treatment of disorders. In certain embodiments, disclosed herein is an extended-release pharmaceutical formulation comprising, in a solid dosage form for oral delivery of between about 100 mg and about 1 g total weight: between about 2 and about 18% of an active ingredient; between about 70% and about 96% of one or more diluents; between about 1% and about 10% of a water-soluble binder and between about 0.5 and about 2% of a surfactant.
    Type: Grant
    Filed: February 5, 2015
    Date of Patent: January 1, 2019
    Assignee: Auspex Pharmaceuticals, Inc.
    Inventors: Andreas Sommer, Chengzhi Zhang, John Carter, John Arthur, Margaret Bradbury
  • HEAD ASSEMBLY WITH FACIAL INSERT FOR CRASH TEST DUMMY
    Publication number: 20180247567
    Abstract: A head assembly for a crash test dummy includes a skull, a head skin disposed over the skull, and a facial insert disposed between the skull and the head skin and having a plurality of defined cell structures to achieve a biomechanical response that provides for evaluation of potential head injuries during vehicle crash testing.
    Type: Application
    Filed: December 19, 2017
    Publication date: August 30, 2018
    Inventors: Zhenwen Jerry Wang, John Arthur, Dominic Isopi
  • Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
    Patent number: 9814708
    Abstract: The present invention relates to new pharmaceutical compositions comprising benzoquinoline compounds, and methods to inhibit vesicular monoamine transporter 2 (VMAT2) activity in a subject for the treatment of chronic hyperkinetic movement disorders.
    Type: Grant
    Filed: February 16, 2016
    Date of Patent: November 14, 2017
    Assignee: Auspex Pharmaceuticals, Inc.
    Inventors: Andreas Sommer, Chengzhi Zhang, John Carter, John Arthur, Margaret Bradbury, Thomas Gant, Manouchehr Shahbaz
  • FORMULATIONS PHARMACOKINETICS OF DEUTERATED BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2
    Publication number: 20170087147
    Abstract: The present invention relates to new pharmaceutical compositions comprising benzoquinoline compounds, and methods to inhibit vesicular monoamine transporter 2 (VMAT2) activity in a subject for the treatment of chronic hyperkinetic movement disorders.
    Type: Application
    Filed: October 6, 2016
    Publication date: March 30, 2017
    Inventors: Andreas Sommer, Chengzhi Zhang, John Carter, John Arthur, Margaret Bradbury, Thomas Gant, Manouchehr Shahbaz
  • Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
    Patent number: 9550780
    Abstract: The present invention relates to new pharmaceutical compositions comprising benzoquinoline compounds, and methods to inhibit vesicular monoamine transporter 2 (VMAT2) activity in a subject for the treatment of chronic hyperkinetic movement disorders.
    Type: Grant
    Filed: March 16, 2016
    Date of Patent: January 24, 2017
    Assignee: Auspex Pharmaceuticals, Inc.
    Inventors: Andreas Sommer, Chengzhi Zhang, John Carter, John Arthur, Margaret Bradbury, Thomas Gant, Manouchehr Shahbaz
  • NOVEL PHARMACEUTICAL FORMULATIONS
    Publication number: 20160346200
    Abstract: The present invention relates to new extended release pharmaceutical compositions and methods of use thereof for the treatment of disorders. In certain embodiments, disclosed herein is an extended-release pharmaceutical formulation comprising, in a solid dosage form for oral delivery of between about 100 mg and about 1 g total weight: between about 2 and about 18% of an active ingredient; between about 70% and about 96% of one or more diluents; between about 1% and about 10% of a water-soluble binder and between about 0.5 and about 2% of a surfactant.
    Type: Application
    Filed: February 5, 2015
    Publication date: December 1, 2016
    Inventors: Andreas SOMMER, Chengzhi ZHANG, John CARTER, John ARTHUR, Margaret BRADBURY
  • FORMULATIONS and PHARMACOKINETICS OF DEUTERATED BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2
    Publication number: 20160235733
    Abstract: The present invention relates to new pharmaceutical compositions comprising benzoquinoline compounds, and methods to inhibit vesicular monoamine transporter 2 (VMAT2) activity in a subject for the treatment of chronic hyperkinetic movement disorders.
    Type: Application
    Filed: February 16, 2016
    Publication date: August 18, 2016
    Inventors: Andreas Sommer, Chengzhi Zhang, John Carter, John Arthur, Margaret Bradbury, Thomas Gant, Manouchehr Shahbaz
  • FORMULATIONS PHARMACOKINETICS OF DEUTERATED BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2
    Publication number: 20160222008
    Abstract: The present invention relates to new pharmaceutical compositions comprising benzoquinoline compounds, and methods to inhibit vesicular monoamine transporter 2 (VMAT2) activity in a subject for the treatment of chronic hyperkinetic movement disorders.
    Type: Application
    Filed: March 16, 2016
    Publication date: August 4, 2016
    Inventors: Andreas Sommer, Chengzhi Zhang, John Carter, John Arthur, Margaret Bradbury, Thomas Gant, Manouchehr Shahbaz